The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders
Tóm tắt
Từ khóa
Tài liệu tham khảo
Merikangas KR et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32–45.
Polanczyk G et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–8.
Merikangas KR et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9.
Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010;122(5):97–109.
Biederman J et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry. 2010;167(4):409–17.
Wilens TE et al. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011;50(6):543–53.
Brook JS et al. Longitudinally predicting late adolescent and young adult drug use: childhood and adolescent precursors. J Am Acad Child Adolesc Psychiatry. 1995;34(9):1230–8.
Johnson BA et al. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population. Am J Addict. 2000;9(1):17–27.
Brook JS et al. Young adult drug use and delinquency: childhood antecedents and adolescent mediators. J Am Acad Child Adolesc Psychiatry. 1996;35(12):1584–92.
Kandel DB et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry. 1999;38(6):693–9.
Lewinsohn PM, Gotlib IH, Seeley JR. Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(9):1221–9.
Frodl T. Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective. J Atten Disord. 2010;14(2):109–20.
Dennis M et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abus Treat. 2004;27(3):197–213.
van Emmerik-van Oortmerssen K et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1-2):11–9.
van de Glind G et al. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res. 2013. doi: 10.1002/mpr.1397 .
McAweeney M et al. Symptom prevalence of ADHD in a community residential substance abuse treatment program. J Atten Disord. 2010;13(6):601–8.
Barkley RA et al. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry. 2004;45(2):195–211.
Galera C et al. Attention problems in childhood and adult substance use. J Pediatr. 2013. doi: 10.1016/j.jpeds.2013.07.008 .
Charach A et al. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry. 2011;50(1):9–21.
Chang Z, Lichtenstein P, Larsson H. The effects of childhood ADHD symptoms on early-onset substance Use: A swedish twin study. J Abnorm Child Psychol. 2012;40(3):425–35.
Groenman AP et al. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study. Addiction. 2013;108(8):1503–11.
Ercan ES et al. Childhood attention deficit/hyeractivity disorder and alcohol dependence: a 1-year follow-up. Alcohol Alcohol. 2003;38(4):352–6.
Biederman J et al. Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders? A controlled study of youths with and without ADHD. Biol Psychiatry. 2006;59:258–64.
Trauth JA, Seidler FJ, Slotkin TA. Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res. 2000;880(1–2):167–72.
Wilens TE et al. Do executive function deficits predict later substance use disorders among adolescents and young adults? J Am Acad Child Adolesc Psychiatry. 2011;50(2):141–9.
King VL et al. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis. 1999;187(8):487–95.
Riggs PD et al. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43(4):420–9.
Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(3):331–2.
Kousha M, Shahrivar Z, Alaghband-Rad J. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor? J Atten Disord. 2012;16(4):325–32.
Biederman J et al. Is ADHD a risk for psychoactive substance use disorder? Findings from a four year follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36:21–9.
Wilens T et al. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict. 2007;16 Suppl 1:14–23.
Wilens TE, Decker MW. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol. 2007;74(8):1212–23.
Casey BJ, Jones RM. Neurobiology of the adolescent brain and behavior: implications for substance use disorders. J Am Acad Child Adolesc Psychiatry. 2010;49(12):1189–201. quiz 1285.
Whelan R et al. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci. 2012. doi: 10.1038/nn.3092 .
Biederman J et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry. 2008;165(1):107–15.
Faraone SV, Biederman J. Neurobiology of attention deficit hyperactivity disorder. In: Charney DS, Nestler EJ, editors. Neurobiology of mental illness. 2nd ed. New York, NY: Oxford University Press; 2004.
Yule AM et al. Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study. Am J Addict. 2013;22(5):460–5.
Bhatara V, Loudenberg R, Ellis R. Association of attention deficit hyperactivity disorder and gestational alcohol exposure: an exploratory study. J Atten Disord. 2006;9(3):515–22.
Schmitz M et al. Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1338–45.
Katusic SK et al. Substance abuse among ADHD cases: a population-based birth cohort study. Seattle: Pediatric Academic Society; 2003.
Molina B, Pelham W. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Child Psychol. 2003;112(3):497–507.
Brook DW et al. Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch Pediatr Adolesc Med. 2010;164(10):930–4.
Flory K, Lynam DR. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play? Clin Child Fam Psychol Rev. 2003;6(1):1–16.
Lee SS et al. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328–41.
Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry. 2007;64(10):1145–52.
Burke JD et al. Inattention as a key predictor of tobacco use in adolescence. J Abnorm Psychol. 2007;116(2):249–59.
Fergusson DM, Horwood LJ, Ridder EM. Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend. 2007;88 Suppl 1:S14–26.
Szobot CM et al. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. Addiction. 2007;102(7):1122–30.
Kollins SH. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin. 2008;24(5):1345–57.
Kuczenski R, Segal DS. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry. 2005;57(11):1391–6.
Humphreys KL, Eng T, Lee SS. Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatr. 2013;70(7):740–9. doi: 10.1001/jamapsychiatry.2013.1273 .
Wilens T et al. Does stimulant therapy of ADHD beget later substance abuse: a metanalytic review of the literature. Pediatrics. 2003;11(1):179–85.
Hammerness P et al. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2012. doi: 10.1016/j.jpeds.2012.06.046 .
Hammerness P et al. Do Stimulants reduce the risk for alcohol and substance use in youth with ADHD? A secondary analysis of a prospective, 24-Month Open-Label Study of Osmotic-Release Methylphenidate. J Atten Disord. 2012;
Lichtenstein P et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367(21):2006–14.
Konstenius M et al. Methylphenidate for ADHD and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction. 2013. doi: 10.1111/add.12369 .
Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–91.
Riggs PD et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011;50(9):903–14.
Tamm L et al. Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. J Subst Abus Treat. 2013;44(2):224–30.
Wilens TE et al. Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin. 2011. doi: 10.1185/03007995.2011.628648 .
National Institute on Drug Abuse, Treatment Approaches for Drug Addiction 2009: National Institute on Drug Abuse, National Institutes of Health.
American Academy of Pediatrics, Recommendations: Attention-Deficit/Hyperactivity Disorder, Center for Disease Control and Prevention, Editor 2013: USA.gov.
National Institute on Drug Abuse, Principles of drug addiction treatment: A research-based guide 2000: National Institute on Drug Abuse, National Institutes of Health.
Antshel KM, Faraone SV and Gordon M. Cognitive behavioral treatment outcomes in adolescent ADHD. J Atten Disord. 2012.
Bramham J et al. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434–41.
Emilsson B et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatr. 2011;11:116.
Solanto MV et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010;167(8):958–68.
Safren SA et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875–80.
Wilens T, Morrison NR and Prince JB. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2011;11(10).
Bukstein OG. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders. 2006.
Wilens TE and Morrison NR. The intersection of attention-deficit/hyperactivity disorder and substance abuse. Curr Opin Psychiatr. 2011;
Wilens TE. Attention -deficit/hyperactivity disorder and substance use disorders in adolescents. Psychiatr Times. 2006;XXV(1): 33–34.
Wilens TE et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96(1–2):145–54.
Adler L et al. Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict. 2009;18(5):393–401.
Thurstone C et al. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(6):573–82.
McRae-Clark AL et al. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010;19(6):481–9.
Levin FR et al. Treatment of methadone-maintained patients with adult ADHD: Double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend. 2006;81:137–48.
Levin FR et al. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend. 2007;87(1):20–9.
Levin FR et al. Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): a preliminary open trial. j dual diagn. 2009;5(1):41–56.
Schubiner H et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol. 2002;10(3):286–94.
Winhusen TM et al. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21(5):455–63.
Safren SA et al. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behavior Research and Therapy. 2005;43(7):831–42.
Weiss M et al. A randomized controlled trial of CBT therapy for adults with ADHD with and without medication. BMC Psychiatry. 2012;12:30.
Philipsen A et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007;195(12):1013–9.
Carroll KM et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 1994;51(3):177–87.
Kaminer Y et al. Psychotherapies for adolescent substance abusers: a pilot study. J Nerv Ment Dis. 1998;186(11):684–90.
Austin AM, Macgowan MJ, Wagner EF. Effective family-based interventions for adolescents with substance use problems: a systematic review. Res Soc Work Pract. 2005;15(2):67–83.
Waldron HB, Turner CW. Evidence-based psychosocial treatments for adolescent substance abuse. J Clin Child Adolesc Psychol. 2008;37(1):238–61.
Wilens T, Zulauf C. ADHD, cigarette smoking, and substance abuse: intoxicating combination. Contemp Pediatr. 2012;29:48–59.
Bates ME et al. Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol Addict Behav. 2006;20(3):241–53.